Endogenous dopamine amplifies ischemic long-term potentiation via D1 receptors

Stroke

Volumn 33, Issue 12, 2002, Pages 2978-2984

  Saulle, Emilia ^a   Centonze, Diego ^a   Martín, Ana B ^b   Moratalla, Rosario ^b   Bernardi, Giorgio ^a   Calabresi, Paolo ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b INSTITUTO CAJAL   (Spain)

Author keywords

Apoptosis; Electrophysiology; Energy metabolism; Excitotoxicity; Neuronal plasticity; Synapses

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; GLUCOSE; N METHYL DEXTRO ASPARTIC ACID; NEUROTOXIN; OXIDOPAMINE; OXYGEN;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; CORPUS STRIATUM; DENERVATION; DOPAMINERGIC SYSTEM; ELECTROPHYSIOLOGY; ENERGY METABOLISM; EXCITATORY POSTSYNAPTIC POTENTIAL; INTRACELLULAR RECORDING; LONG TERM POTENTIATION; MICROELECTRODE; MOUSE; NERVE CELL LESION; NERVE CELL MEMBRANE STEADY POTENTIAL; NERVE CELL PLASTICITY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; SYNAPSE;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; BRAIN ISCHEMIA; CORPUS STRIATUM; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DENERVATION; DOPAMINE; DOPAMINE ANTAGONISTS; ENERGY METABOLISM; EXCITATORY AMINO ACID ANTAGONISTS; EXCITATORY POSTSYNAPTIC POTENTIALS; GLUCOSE; LONG-TERM POTENTIATION; MEMBRANE POTENTIALS; MICE; MICE, KNOCKOUT; NEURONS; OXIDOPAMINE; PERFUSION; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D1; RECEPTORS, N-METHYL-D-ASPARTATE; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

EID: 0036904941     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000038093.42512.0F     Document Type: Article

References (45)

1. Francis A, Pulsinelli W. The response of GABAergic and cholinergic neurons to transient cerebral ischemia. Brain Res. 1982;243:271-278.
2. Pulsinelli WA. Selective neuronal vulnerability: Morphological and molecular characteristics. Prog Brain Res. 1985;63:29-37.
3. Chesselet M-F, Gonzales C, Lin CS, Polsky K, Jin BK. Ischemic damage in the striatum of adult gerbils: Relative sparing of somatostatinergic and cholinergic interneurons contrasts with loss of efferent neurons. Exp Neurol. 1990;110:209-218.
4. Calabresi P, Marfia GA, Centonze D, Pisani A, Bemardi G. Sodium influx plays a major role in the membrane depolarization induced by oxygen and glucose deprivation in rat striatal spiny neurons. Stroke. 1999;30:171-179.
5. Obrenovitch TP, Urenjak J. Altered glutamatergic transmission in neurological disorders: From high extracellular glutamate to excessive synaptic efficacy. Prog Neurobiol. 1997;51:39-87.
6. Lee J-M, Zipfel GJ, Choi DW. The changing landscape of ischaemic brain injury mechanisms. Nature. 1999;399(suppl):A7-A14.
7. Ueda Y, Obrenovitch TP, Lok SY, Sarna GS, Symon L. Efflux of glutamate produced by short ischemia of varied severity in rat striatum. Stroke. 1992;23:253-259.
8. Greene JG, Greenamyre JT. Bioenergetics and glutamate excitotoxicity. Prog Neurobiol. 1996;48:613-634.
9. Seki Y, Feustel PJ, Keller RW Jr, Tranmer BI, Kimelberg HK. Inhibition of ischemia-induced glutamate release in rat striatum by dihydrokinate and an anion channel blocker. Stroke. 1999;30:433-440.
10. Simon RP, Swan JH, Griffiths T, Meldrum BS. Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. Science. 1984;226:850-852.
11. Le Peillet E, Arvin B, Moncada C, Meldrum BS. The non-NMDA antagonists. NBQX and GYKI 52466, protect against cortical and striatal cell loss following transient global ischaemia in the rat. Brain Res. 1992;571:115-120.
12. Hickenbottom SL, Grotta J. Neuroprotective therapy. Semin Neurol. 1998;18:485-492.
13. Toner CC, Stamford JA. "Real time" measurement of dopamine release in an in vitro model of neostriatal ischemia. J Neurosci Methods. 1996;67: 133-140.
14. Furukawa N, Arai N, Goshima Y, Miyamae T, Ohshima E, Suzuki F, Fujita K, Misu Y. Endogenously released DOPA is a causal factor for glutamate release and resultant delayed neuronal cell death by transient ischemia in rat striata. J Neurochem. 2001;76:815-824.
15. Toner CC, Connelly K, Whelpton R, Bains S, Michael-Titus AT, McLaughlin DP, Stamford JA. Effects of sevoflurane on dopamine, glutamate and aspartate release in an in vitro model of cerebral ischaemia. Br J Anaesth. 2001;86:550-554.
16. Buisson A, Callebert J, Mathieu E, Plotkine M, Boulu RG. Striatal protection induced by lesioning the substantia nigra of rats subjected to focal ischemia. J Neurochem. 1992;59:1153-1157.
17. Calabresi P, Saulle E, Marfia GA, Centonze D, Mulloy R, Picconi B, Hipskind RA, Conquer F, Bernardi G. Activation of metabotropic glutamate receptor subtype 1/protein kinase C/mitogen-activated protein kinase pathway is required for postischemic long-term potentiation in the striatum. Mol Pharmacol. 2001;60:808-815.
18. Xu M, Moratalla R, Gold LH, Hiroi N, Koob GF, Graybiel AM, Tonegawa S. Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell. 1994;79:729-742.
19. Calabresi P, Mercuri NB, Sancesario G, Bernardi G. Electrophysiology of dopamine-denervated striatal neurons: Implications for Parkinson's disease. Brain. 1993;116:433-452.
20. Calabresi P, Magarinos Ascone C, Centonze D, Pisani A, Sancesario G, D'Angelo V, Bernardi G. Opposite membrane potential changes induced by glucose deprivation in striatal spiny neurons and in large aspiny interneurons. J Neurosci. 1997;17:1940-1949.
21. Jiang C, Haddad GG. Differential responses of neocortical neurons to glucose and/or O2 deprivation in the human and rat. J Neurophysiol. 1992;68:2165-2173.
22. Calabresi P, Saulle E, Centonze D, Pisani A, Marfia GA, Bernardi G. Post-ischaemic long-term synaptic potentiation in the striatum: A putative mechanism for cell type-specific vulnerability. Brain. 2002;125: 844-860.
23. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. Sydney, Australia: Academic; 1986.
24. Centonze D, Gubellini P, Picconi B, Calabresi P, Giacomini P, Bernardi G. Unilateral dopamine denervation blocks corticostriatal LTP. J Neurophysiol. 1999;82:3575-3579.
25. Stoof JC, Kebabian JW. Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum. Nature. 1981; 294:366-368.
26. Greengard P, Allen PB, Nairn AC. Beyond the dopamine receptor: The DARPP-32/protein phosphatase-1 cascade. Neuron. 1999;23:435-447.
27. Otani S, Auclair N, Desce J-M, Roisin MP, Crépel F. Dopamine receptors and group I and II mGluRs cooperates for long-term depression induction in rat prefrontal cortex through converging postsynaptic activation of MAP kinases. J Neurosci. 1999; 19:9788-9802.
28. Calabresi P, Gubellini P, Centonze D, Picconi B, Bernardi G, Chergui K, Svenningsson P, Fienberg AA, Greengard P. Dopamine and cyclic adenosine 3′,5′ monophosphate-regulated phosphoprotein 32 kDa controls both striatal long-term depression and long-term potentiation, opposing forms of synaptic plasticity. J Neurosci. 2000;20:8443-8451.
29. Uehara T, Tabuchi M, Mori E. Risk factors for silent cerebral infarcts in subcortical white matter and basal ganglia. Stroke. 1999;30:378-382.
30. Weinberger J, Thompson L, Samii M. The significance of basal ganglia infarction. J Stroke Cerebrovasc Dis. 1995;5:6-11.
31. Gao WJ, Krimer LS, Goldman-Rakic PS. Presynaptic regulation of recurrent excitation by D1 receptors in prefrontal circuits. Proc Natl Acad Sci USA. 2001;98:295-300.
32. Seamans JK, Durstewitz D, Christie BR, Stevens CF, Sejnowski TJ. Dopamine D1/D5 receptor modulation of excitatory synaptic inputs to layer V prefrontal cortex neurons. Proc Natl Acad Sci USA. 2001;98: 301-306.
33. Centonze D, Picconi B, Gubellini P, Bernardi G, Calabresi P. Dopaminergic control of synaptic plasticity in the dorsal striatum. Eur J Neurosci. 2001;13:1071-1077.
34. Dingledine R, Borges K, Bowie D, Traynelis SF. The glutamate receptor ion channels. Pharmacol Rev. 1999;51:7-61.
35. Stern EA, Jaeger D, Wilson CJ. Membrane potential synchrony of simultaneously recorded striatal spiny neurons in vivo. Nature. 1998;394: 475-478.
36. Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischemic stroke. Trends Neurosci. 1999;22:391-397.
37. Nellgard B, Wieloch T. Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia. J Cereb Blood Flow Metab. 1992;12:2-11.
38. Roy M, Sapolsky R. Neuronal apoptosis in acute necrotic insults: Why is this subject such a mess? Trends Neurosci. 1999;22:419-422.
39. Colbourne F, Li H, Buchan AM, Clemens JA. Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia. Stroke. 1999;30: 662-668.
40. Yan Z, Hsieh-Wilson L, Feng J, Tomizawa K, Allen PB, Fienberg AA, Nairn AC, Greengard P. Protein phosphatase 1 modulation of neostriatal AMPA channels: Regulation by DARPP-32 and spinophilin. Nat Neurosci. 1999;2:13-17.
41. Ferrante RJ, Kowall NW, Beal MF, Richardson EP, Bird ED, Martin JB. Selective sparing of a class of striatal neurons in Huntington's disease. Science. 1985;230:561-563.
42. Calabresi P, Centonze D, Pisani A, Sancesario G, Gubellini P, Marfia GA, Bernardi G. Striatal spiny neurons and cholinergic interneurons express differential ionotropic glutamatergic responses and vulnerability: Implications for ischemia and Huntington's disease. Ann Neurol. 1998; 43:586-597.
43. Surmeier DJ, Bargas J, Hemmings HC Jr, Nairn AC, Greengard P. Modulation of calcium currents by D1 dopaminergic protein kinase/phosphatase cascade in rat neostriatal neurons. Neuron. 1995;14: 385-397.
44. Khan FH, Saha M, Chakrabarti S. Dopamine induced protein damage in mitochondrial-synaptosomal fraction of the brain. Brain Res. 2001;895: 245-249.
45. Vallone D, Picetti P, Borrelli E. Structure and function of dopamine receptors. Neurosci Biobehav Rev. 2000;24:125-132.